ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

February 1, 2013

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002